Full sequencing (in particular, using gene panels including BRCA1/2) is warranted in women with early-onset breast cancer, in particular for those with a positive family history and those with breast cancers with clinical features characteristic of BRCA1-related tumors. Here, BRCA1 is linked to breast cancer.